Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig

被引:40
|
作者
Bowes, J
Ruetten, H
Martorana, PA
Stockhausen, H
Thiemermann, C
机构
[1] St Bartholomews & Royal London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England
[2] Hoechst Marion Roussel, Cardiovasc Agents, Frankfurt, Germany
关键词
PARS (poly (adenosine 5 '-diphosphate ribose) synthetase); heart; reperfusion injury; oxygen radical; cardiomyoblast; human; (Pig);
D O I
10.1016/S0014-2999(98)00638-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of the Poly (adenosine 5'-diphosphate ribose) synthetase (PARS) inhibitor 3-aminobenzamide on (i) infarct size caused by regional myocardial ischaemia (60 min) and reperfusion (3 h) in the anaesthetised pig, and (ii) on the cell injury/necrosis of human cardiomyoblasts caused by hydrogen peroxide (3 mM) was investigated. Regional myocardial ischaemia and reperfusion resulted in an infarct size of 66 +/- 3% of the area at risk, which was reduced by 3-aminobenzamide (to 44 +/- 2%, n = 6), but not 3-aminobenzoic acid (66 +/- 5%, n = 4). 3-aminobenzamide also reduced the postischaemic contractile dysfunction. 3-aminobenzamide, but not 3-aminobenzoic acid, abolished the increase in PARS activity as well as the cell injury/necrosis caused by hydrogen peroxide in the cardiomyoblasts. in conclusion, the PARS inhibitor 3-aminobenzamide reduces myocardial reperfusion injury in the pig, and attenuates the cell injury and death associated with oxidant stress in human cardiomyoblasts. We propose that the activation of PARS plays an important role in the injury associated with oxidant stress of the heart. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:143 / 150
页数:8
相关论文
共 50 条
  • [1] Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase
    Zingarelli, B
    Cuzzocrea, S
    Zsengellér, Z
    Salzman, AL
    Szabó, C
    CARDIOVASCULAR RESEARCH, 1997, 36 (02) : 205 - 215
  • [2] Poly (ADP-ribose) synthetase activation induced by peroxynitrite mediates myocardial ischemia and reperfusion injury
    Zingarelli, B
    Cuzzocrea, S
    OConnor, M
    Zsengeller, Z
    Salzman, AL
    Szabo, C
    4TH INTERNATIONAL CONGRESS ON THE IMMUNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS: MECHANISMS AND THERAPEUTIC APPROACHES, 1996, : 681 - 685
  • [3] Effects of an inhibitor poly(ADP-ribose) polymerase cardiac ischaemia and reperfusion in the pig
    Ruetten, H
    Busch, A
    Martorana, P
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R632 - R632
  • [4] POLY(ADP-RIBOSE) SYNTHETASE
    UEDA, K
    ZHANG, JY
    HAYAISHI, O
    METHODS IN ENZYMOLOGY, 1984, 106 : 500 - 504
  • [5] HISTONE IS AN ACTIVATOR OF PURIFIED POLY(ADP-RIBOSE) SYNTHETASE, NOT AN ACCEPTOR OF POLY(ADP-RIBOSE)
    EDSON, CM
    OKAYAMA, H
    FUKUSHIMA, M
    HAYAISHI, O
    FEDERATION PROCEEDINGS, 1976, 35 (07) : 1722 - 1722
  • [6] Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion
    Szabó, C
    Dawson, VL
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (07) : 287 - 298
  • [7] Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor
    Faro, R
    Toyoda, Y
    McCully, JD
    Jagtap, P
    Szabo, E
    Virag, L
    Bianchi, C
    Levitsky, S
    Szabo, C
    Sellke, FW
    ANNALS OF THORACIC SURGERY, 2002, 73 (02): : 575 - 581
  • [8] POLY(ADP-RIBOSE) SYNTHETASE, A MAIN ACCEPTOR OF POLY(ADP-RIBOSE) IN ISOLATED-NUCLEI
    OGATA, N
    UEDA, K
    KAWAICHI, M
    HAYAISHI, O
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1981, 256 (09) : 4135 - 4137
  • [9] Poly(ADP-ribose) polymerase in ischemia-reperfusion injury
    Dawson, VL
    Dawson, TM
    CEREBROVASCULAR DISEASE: MOMENTUM AT THE END OF THE SECOND MILLENNIUM, 2001, : 61 - 74
  • [10] Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase
    Liaudet, L
    Yang, ZQ
    Al-Affar, EB
    Szabó, C
    MOLECULAR MEDICINE, 2001, 7 (06) : 406 - 417